 |
MorphoSys AG
MOR
|
1.28 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Alterity Therapeutics Limited
ATHE
|
125 |
$ 3.6 |
1.34 % |
$ 8.66 B |
Australia |
 |
Aytu BioScience
AYTU
|
0.127 |
$ 2.66 |
- |
$ 16.7 M |
USA |
 |
BioNTech SE
BNTX
|
5.29 |
$ 91.28 |
- |
$ 27.2 B |
Germany |
 |
I-Mab
IMAB
|
1.12 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
596 |
- |
2.54 % |
$ 160 B |
France |
 |
Burford Capital Limited
BUR
|
1.26 |
$ 4.48 |
- |
$ 736 M |
Britain |
 |
Biophytis SA
BPTS
|
15.7 |
- |
-13.47 % |
$ 169 M |
France |
 |
Cerus Corporation
CERS
|
7.63 |
$ 1.85 |
- |
$ 353 M |
USA |
 |
Midatech Pharma plc
MTP
|
7.56 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Acorda Therapeutics
ACOR
|
0.154 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Coherus BioSciences
CHRS
|
3.71 |
$ 1.67 |
- |
$ 196 M |
USA |
 |
Celldex Therapeutics
CLDX
|
3.87 |
$ 31.37 |
- |
$ 2.08 B |
USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
2.09 |
$ 0.44 |
- |
$ 5.04 M |
Israel |
 |
Advaxis
ADXS
|
0.113 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Adverum Biotechnologies
ADVM
|
1.08 |
- |
- |
$ 86.2 M |
USA |
 |
CNS Pharmaceuticals
CNSP
|
0.234 |
$ 2.32 |
- |
$ 1.03 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 |
- |
- |
- |
Russia |
 |
Catalyst Pharmaceuticals
CPRX
|
3.19 |
$ 24.98 |
- |
$ 3.05 B |
USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
0.862 |
$ 10.14 |
- |
$ 135 M |
USA |
 |
Cardiff Oncology
CRDF
|
2.56 |
$ 1.58 |
- |
$ 106 M |
USA |
 |
Curis
CRIS
|
1.74 |
$ 0.53 |
- |
$ 6.98 M |
USA |
 |
Crinetics Pharmaceuticals
CRNX
|
4.14 |
$ 37.7 |
- |
$ 3.55 B |
USA |
 |
CRISPR Therapeutics AG
CRSP
|
2.28 |
$ 49.15 |
- |
$ 4.42 B |
Schweiz |
 |
Aeterna Zentaris
AEZS
|
0.781 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
0.00262 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Citius Pharmaceuticals
CTXR
|
0.327 |
$ 0.86 |
- |
$ 5.79 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 |
- |
- |
$ 1.01 B |
USA |
 |
Cue Biopharma
CUE
|
1.11 |
$ 0.18 |
- |
$ 17.1 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.382 |
- |
- |
$ 26.5 M |
USA |
 |
DBV Technologies S.A.
DBVT
|
16.7 |
$ 20.36 |
- |
$ 2.84 B |
France |
 |
AIkido Pharma
AIKI
|
0.492 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Aptose Biosciences
APTO
|
-0.511 |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
Denali Therapeutics
DNLI
|
2.47 |
$ 19.38 |
- |
$ 3.19 B |
USA |
 |
Dyadic International
DYAI
|
25.5 |
$ 0.87 |
-2.8 % |
$ 31.5 M |
USA |
 |
Akero Therapeutics
AKRO
|
4.34 |
- |
- |
$ 3.67 B |
USA |
 |
CureVac N.V.
CVAC
|
5.13 |
- |
- |
$ 867 M |
Germany |
 |
Akari Therapeutics, Plc
AKTX
|
285 |
$ 3.54 |
- |
$ 238 B |
Britain |
 |
Akouos
AKUS
|
0.736 |
- |
0.23 % |
$ 488 M |
USA |
 |
Entera Bio Ltd.
ENTX
|
4.59 |
$ 1.19 |
- |
$ 55.5 M |
Israel |
 |
Equillium
EQ
|
4.13 |
$ 2.01 |
- |
$ 115 M |
USA |
 |
Allakos
ALLK
|
0.674 |
- |
- |
$ 28.6 M |
USA |
 |
Allena Pharmaceuticals
ALNA
|
3.16 |
- |
3.16 % |
$ 1.9 M |
USA |
 |
Alnylam Pharmaceuticals
ALNY
|
51.7 |
$ 330.34 |
- |
$ 43.3 B |
USA |
 |
Alpine Immune Sciences
ALPN
|
1.5 |
- |
- |
$ 2.17 B |
USA |
 |
Fate Therapeutics
FATE
|
0.585 |
$ 1.19 |
- |
$ 141 M |
USA |
 |
Aileron Therapeutics
ALRN
|
0.702 |
- |
10.36 % |
$ 9.8 M |
USA |